Tecan has integrated agentic AI capabilities into its Introspect™ lab analytics platform, using the NVIDIA BioNeMo Agent Toolkit. The move lets pharmaceutical, biotechnology, and clinical labs shift from reactive monitoring to proactive, data-driven decisions that can prevent problems before they affect performance, quality, or scientific outcomes.
The collaboration between Tecan and NVIDIA marks a step toward data-driven laboratories that use AI to speed up scientific discovery and improve lab productivity. By embedding NVIDIA's toolkit into Introspect, Tecan is building a more intelligent, connected lab ecosystem that supports complex workflows, high-throughput operations, and scalable digital transformation.
How agentic AI changes lab operations
Instead of flagging problems after they happen, intelligent AI agents now continuously analyze lab data, workflows, and system performance. They uncover hidden patterns that limit throughput, constrain scalability, or reduce operational efficiency. The system then turns raw data into recommended actions.
This allows labs to accelerate decision-making across research, development, and clinical workflows. It helps optimize use of instruments, consumables, and personnel. Labs can also improve overall productivity and uptime, and support more consistent quality and reproducible scientific outcomes. Early access to the enhanced platform is available, with initial applications focused on pharmaceutical, biotechnology, and clinical labs where complex, data-intensive workflows demand strong automation and analytics.
Responsible and reliable AI for the lab
Tecan and NVIDIA are also focusing on the guardrails needed for responsible AI in the lab. These safeguards support transparency, reliability, and controlled automation, helping to establish agentic AI as a trusted technology for key research and operational workflows. By prioritizing governance and clear operational boundaries, the companies aim to ensure AI-driven recommendations align with regulatory expectations, quality standards, and institutional policies.
Next-gen lab instrumentation with Physical AI
The two companies will continue developing AI-enabled platforms for data-driven labs. This includes using Physical AI to enable next-generation lab instruments that integrate intelligent software agents with advanced hardware. The goal is more autonomous, efficient, and adaptable laboratory systems, supporting applications from drug discovery and bioprocessing to clinical diagnostics by connecting data, instruments, and AI in a unified, scalable ecosystem.
Mukta Acharya, Executive Vice President - Head of the Life Sciences Business division at Tecan, said, "Agentic AI has the potential to reshape how laboratories operate. By combining Tecan's laboratory expertise with NVIDIA's BioNeMo Agent Toolkit, we are enabling a new generation of intelligent laboratory solutions that can proactively support scientists, improve productivity, and help accelerate scientific outcomes."
This integration reflects a broader industry move toward AI-enabled, data-centric labs that can adapt to changing demands. For professionals tracking these shifts, resources on AI Agents & Automation offer deeper context on how agentic systems are reshaping technical workflows.
Why this matters for science and research professionals
For scientists and lab managers, the shift to agentic AI means moving from a world where problems are detected after the fact to one where they are anticipated and headed off. This can reduce downtime, improve resource use, and make experimental results more reproducible. As labs face pressure to deliver faster, more reliable outcomes, tools that combine AI with existing automation platforms offer a practical path to higher productivity without requiring a complete overhaul of established workflows.
Your membership also unlocks:
